FDA advisers support Acthar as treatment for infantile spasms

05/7/2010 | Reuters

An FDA panel endorsed the approval of Questcor Pharmaceuticals' injectable gel Acthar for infantile spasms. The drug is already approved for other indications, including multiple sclerosis.

View Full Article in:

Reuters

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Chief Executive Officer
CarePoint Health Plan
Jersey City, NJ
Regional Director, Southeastern Region - State Affairs
America's Heatlh Insurance Plans (AHIP)
Washington, DC
Assistant General Counsel
Cardinal Health
Columbus, OH
Pharmacy Care Manager
National Association of Chain Drug Stores
Arlington, VA
Senior Director, Research
America's Health Insurance Plans (AHIP)
Washington, DC